Previous close | 3.7800 |
Open | 3.7900 |
Bid | 3.7600 x N/A |
Ask | 3.7800 x N/A |
Day's range | 3.7500 - 3.8000 |
52-week range | 2.4500 - 3.9000 |
Volume | |
Avg. volume | 59,295 |
Market cap | 319.269M |
Beta (5Y monthly) | 1.01 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1800 |
Earnings date | 07 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.36 |
MIAMI, March 05, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 68th Emerging Growth Conference on March 6 & 7, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani
LIMERICK, Ireland, Feb. 28, 2024 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that it has signed a Master Services Agreement with a global provider of critical care products. The Agreement, which initially is for Equipment Validation, allows the company to scale Kneat to all its global validation processes. Headquartered in the United States with more than 50,000 employees worldwide and
LIMERICK, Ireland, Feb. 21, 2024 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, today announced financial results for the three- and twelve-month periods ended December 31, 2023. All dollar amounts are presented in Canadian dollars unless otherwise stated. Annual Recurring Revenue (ARR)1 at December 31, 2023, reaches $37.4 million, an increase of 55% year over year, and 19% from $31.4